期刊文献+

长链非编码RNA在膀胱癌中的研究进展 被引量:4

The research progress of long non-coding RNA in bladder cancer
下载PDF
导出
摘要 长链非编码RNA(long non-coding RNA,lncRNA)起初被认为是基因组转录的"噪音"或"转录垃圾"。随着研究的深入和测序技术的发展,越来越多的lncRNA被发现,虽然lncRNA不编码蛋白质,但可在多层面、通过多途径调控基因表达,从而影响疾病的发生、发展,尤其与肿瘤的发生、发展密不可分。膀胱癌是泌尿系统最常见的恶性肿瘤,其高发病率和高复发率一直是泌尿外科医生和膀胱癌患者的困扰,且病因尚不十分明确。lncRNA与膀胱癌的关系也逐渐受到关注,本文以几个lncRNA(H19,UCA1/UCA1a,MALAT-1,HOTAIR,ncRAN,MEG3)为代表,阐述了lncRNA与膀胱癌的发生、发展与复发的密切关系,并预测通过lncRNA诊断和治疗膀胱癌的临床前景。 Long non - coding RNAs ( lncRNAs ) were initially considered as transcriptional "noise" or "junk". With in -depth researches,it was found that lncRNAs could regulate gene expression at multiple levels and pathways and thus affect the occurrence and progression of various diseases including some malignant tumors although no protein products are encoded. Bladder cancer is the most common malignant tumor of urinary system. Its pathogenesis involvesthe effects of various lncRNAs. Taking several lncRNAs ( H19, UCA1/UCAla, MALAT - 1, HOTAIR, ncRAN, MEG3 ) as examples, this review elaborates on the effects of lncRNAs on bladder cancer and predicts the applications of relat- ed lncRNAs in diagnosing and treating bladder cancer.
出处 《现代肿瘤医学》 CAS 2015年第24期3685-3690,共6页 Journal of Modern Oncology
基金 国家自然基金(编号:81460450) 海南省自然基金资助项目(编号:813256) 海南省重点项目(编号:ZDXM2014076) 海口市重点资助项目(编号:2012-073)
关键词 膀胱癌 长链非编码RNA 肿瘤复发 bladder cancer, lncRNA, tumor recurrence
  • 相关文献

参考文献3

二级参考文献22

  • 1Brodeur GM. Neuroblastoma:biological insights into a clinical enigma [J]. Nature Rev Cancer, 2003,3 ( 3 ) : 203-216. 被引量:1
  • 2Riley RD,Heney D,Jones DR,et al. A systematic review of molecular and biological tumor markers in neuroblastoma [J]. Clin Cancer Res, 2004,10 ( 1 Pt 1 ) :4-12. 被引量:1
  • 3Attiyeh EF,London WB,Mosse YP,et al. Chromosome 1p and 11q deletions and outcome in neuroblastoma [J]. N Engl J Med,2005, 353 (21) :2243-2253. 被引量:1
  • 4Morowitz M,Shusterman S,Mosse Y,et al. Detection of single-copy chromosome 17q gain in human neuroblastomas using real-time quantitative polymerase chain reaction [J]. Mod Pathol,2003,16 (12) : 1248-1256. 被引量:1
  • 5Combaret V, Brejon S,Iaeono l,et al. Determination of 17q gain in patients with neuroblastoma by analysis of circulating DNA [J]. Pediatr Blood Cancer, 2011,56 (5) : 757-761. 被引量:1
  • 6Ohira M,Morohashi A,lnuzuka H,et al. Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas : identification of 305 genes differentially expressed between favorable and unfavorable subsets [ J ]. Oncogene, 2003,22 ( 35 ) : 5525-5536. 被引量:1
  • 7Islam A, Kageyama H,Takada N,et al. High expression of Sarvivin, mapped to 17q25,is significantly associated with poor prognostie factors and promotes cell survival in human neuroblastoma [J]. Oncogene,2000,19 (5) :617-623. 被引量:1
  • 8Lotan Y,Svatek RS,Sagalowsky AI.Should we screen for bladder cancer in a high risk population? A cost per life-year saved analysis.Cancer,2006,107:982-990. 被引量:1
  • 9van Rhijn BW,van der Poel HG,van der Kwast TH. Urine markers for bladder cancer surveillance:a systematic review.Eur Urol,2005,47:736-748. 被引量:1
  • 10Budman LI,Kassouf W,Steinberg JR.Biomarkers for detection and surveillance of bladder cancer.Can Urol Assoc J,2008,2:212-221. 被引量:1

共引文献100

同被引文献28

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部